ACTRN12605000386639Not yet recruitingNot Applicable
Frusemide infusion for the prevention of deterioration in renal function post cardiac surgery.
Intensive Care Unit, RMH0 sites400 target enrollmentStarted: September 14, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Prevention
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to ot stated (—)
- Sex
- All
Inclusion Criteria
- •All patients admitted for cardiac surgery will be assessed for eligibility. Participants will be approached for inclusion from the pre-admission clinics, and wards of the Cardiothoracic surgery unit. Potential participants will be identified by daily review of planned cardiothoracic surgery schedules. Prior to inclusion in this study permission to approach patients will be obtained from involved treating Intensivists and Surgeons.
Exclusion Criteria
- •Patients will be excluded if:1.already in established dialysis dependent chronic renal failure.2.known allergy to frusemide. 3.age < 184.Pregnant.
Investigators
Similar Trials
Withdrawn
Not Applicable
Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.Renal Impairment After Cardiac SurgeryNCT00246675Melbourne Health
Not yet recruiting
Not Applicable
ebulised frusemide to imporve the sensation and unpleasant feeling of dyspnoea in patients with advanced diseases and breathlessness refractory to optimal standard managementDyspnoea in advanced diseasesRespiratory - Other respiratory disorders / diseasesACTRN12612000778886Dr Maria Cristina Cigolini45
Completed
Phase 3
Intermittent furosemide therapy as a prophylaxis of acute renal failure in CABG patientsCoronary artery disease.Atherosclerotic heart diseaseIRCT201502122804N8Vice chancellor for research, Shahid Rajaei Heart Center123
Not yet recruiting
Phase 3
Efficacy of furosemide for prevention of volume overload in children with transfusion-dependent thalassemia at Phramongkutklao hospitalundrelying thalassemia who receive blood transfusiontransfusion,thalassemia,furosemideTCTR20180209001phramongkutklao hospital20
Completed
Phase 4
A clinical trial intended to study the effect of drug dexmedetomidine in preventing agitation in adults after surgery under general anaesthesiaCTRI/2018/02/012197Tejesh CA100